ZHANG; Dezhu

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHANG; Dezhu.The latest application filed is for "syringa pubescens seed extract, its preparation and application in antibiotic-resistant infections".

Company Profile

12.16.6

ZHANG; Dezhu - Xi'an CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Syringa Pubescens Seed Extract, Its Preparation And Application In Antibiotic-resistant Infections App 20220160805 - YANG; Dan ; et al.	2022-05-26
Method for extracting herbal medicine Grant 11,219,652 - Xie , et al. January 11, 2	2022-01-11
Gossypol isocyanate ester compounds with antileukemic activities and a method of preparing the same Grant 10,858,312 - Xie , et al. December 8, 2	2020-12-08
Method For Extracting Herbal Medicine App 20200376056 - XIE; Xiaolin ; et al.	2020-12-03
Gossypol isatin schiff base compounds with antitumor activities and a method of preparing the same Grant 10,729,675 - Liang , et al.	2020-08-04
Gossypol 7-N-isatin Schiff base compounds with antitumor activities and a method of preparing the same Grant 10,722,500 - Xie , et al.	2020-07-28
Gossypol Isatin Schiff Base Compounds With Antitumor Activities And A Method Of Preparing The Same App 20200147042 - LIANG; Chengyuan ; et al.	2020-05-14
Gossypol 7-n-isatin Schiff Base Compounds With Antitumor Activities And A Method Of Preparing The Same App 20200147057 - XIE; Xiaolin ; et al.	2020-05-14
Gossypol eflornithine Schiff base compound with antitumor activities and a method of preparing the same Grant 10,336,689 - Liang , et al.	2019-07-02
Gossypol l-arginine schiff base compound with antitumor activities and a method of preparing the same Grant 9,975,849 - Xie , et al. May 22, 2	2018-05-22
Edaravone-gossypol derivatives with antitumor activities and a method of preparing the same Grant 9,758,486 - Liang , et al. September 12, 2	2017-09-12
Coumarin-gossypol derivatives with antitumor activities and a method of preparing the same Grant 9,758,503 - Liang , et al. September 12, 2	2017-09-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.